{"id":"https://openalex.org/W3047589966","doi":"https://doi.org/10.1021/acs.jmedchem.0c00566","title":"Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype","display_name":"Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype","alternate_titles":[],"publication_year":2020,"publication_date":"2020-08-03","ids":{"openalex":"https://openalex.org/W3047589966","doi":"https://doi.org/10.1021/acs.jmedchem.0c00566","mag":"3047589966","pmid":"https://pubmed.ncbi.nlm.nih.gov/32787145"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.0c00566","doi":"https://doi.org/10.1021/acs.jmedchem.0c00566","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00566","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3047589966"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029744254","display_name":"Christopher R. Wellaway","orcid":"https://orcid.org/0000-0003-0077-3452","observed_orcids":["https://orcid.org/0000-0003-0077-3452"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christopher R. Wellaway","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-0077-3452","affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011795002","display_name":"Paul Bamborough","orcid":"https://orcid.org/0000-0001-9479-2894","observed_orcids":["https://orcid.org/0000-0001-9479-2894"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Bamborough","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-9479-2894","affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041081820","display_name":"Sharon G. Bernard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sharon G. Bernard","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059463978","display_name":"Chun\u2010wa Chung","orcid":"https://orcid.org/0000-0002-2480-3110","observed_orcids":["https://orcid.org/0000-0002-2480-3110"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chun-wa Chung","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-2480-3110","affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020875571","display_name":"Peter D. Craggs","orcid":"https://orcid.org/0000-0002-9546-6617","observed_orcids":["https://orcid.org/0000-0002-9546-6617"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter D. Craggs","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003336751","display_name":"Leanne Cutler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leanne Cutler","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009737267","display_name":"Emmanuel H. Demont","orcid":"https://orcid.org/0000-0001-7307-3129","observed_orcids":["https://orcid.org/0000-0001-7307-3129"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emmanuel H. Demont","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0001-7307-3129","affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John P. Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John P. Evans","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002254682","display_name":"Laurie J. Gordon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laurie Gordon","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069477129","display_name":"Bhumika Karamshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bhumika Karamshi","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113531428","display_name":"Antonia J. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonia J. Lewis","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033598836","display_name":"Matthew J. Lindon","orcid":"https://orcid.org/0000-0001-9767-5079","observed_orcids":["https://orcid.org/0000-0001-9767-5079"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew J. Lindon","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021237377","display_name":"Darren J. Mitchell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darren J. Mitchell","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068014083","display_name":"Inmaculada Rioja","orcid":"https://orcid.org/0000-0002-0533-2253","observed_orcids":["https://orcid.org/0000-0002-0533-2253"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Inmaculada Rioja","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084163133","display_name":"Peter E. Soden","orcid":"https://orcid.org/0000-0001-7757-9354","observed_orcids":["https://orcid.org/0000-0001-7757-9354"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter E. Soden","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Simon Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon Taylor","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000546994","display_name":"Robert J. Watson","orcid":"https://orcid.org/0000-0003-3146-3457","observed_orcids":["https://orcid.org/0000-0003-3146-3457"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert J. Watson","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rob Willis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Willis","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059748606","display_name":"James M. Woolven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James M. Woolven","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070604160","display_name":"Beata S. Wyspianska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beata S. Wyspia\u0144ska","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012286804","display_name":"William J. Kerr","orcid":"https://orcid.org/0000-0002-1332-785X","observed_orcids":["https://orcid.org/0000-0002-1332-785X"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William J. Kerr","raw_affiliation_strings":["Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-1332-785X","affiliations":[{"raw_affiliation_string":"Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, United Kingdom","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029447427","display_name":"Rab K. Prinjha","orcid":"https://orcid.org/0000-0002-2666-3326","observed_orcids":["https://orcid.org/0000-0002-2666-3326"]},"institutions":[{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rab K. Prinjha","raw_affiliation_strings":["GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom","institution_ids":["https://openalex.org/I4405268060"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5029744254"],"corresponding_institution_ids":["https://openalex.org/I4405268060"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":2.4121,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.90712802,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"63","issue":"17","first_page":"9020","last_page":"9044"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.8450000286102295},{"id":"https://openalex.org/keywords/i-bet151","display_name":"I-BET151","score":0.8450000286102295},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7760000228881836},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.6980000138282776},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9929999709129333},{"id":"https://openalex.org/keywords/epigenetic-modifiers","display_name":"epigenetic regulators","score":0.8529999852180481},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.718999981880188},{"id":"https://openalex.org/keywords/brd2","display_name":"BRD2","score":0.796999990940094},{"id":"https://openalex.org/keywords/brd3","display_name":"BRD3","score":0.9020000100135803},{"id":"https://openalex.org/keywords/brdt","display_name":"BRDT","score":0.9760000109672546}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.996729850769043},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.8820215463638306},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6609992384910583},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.6584593057632446},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.6254121661186218},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.6178115010261536},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4932186007499695},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4252821207046509},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.32780593633651733},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3273007571697235},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21573147177696228},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11283531785011292}],"mesh":[{"descriptor_ui":"D000072417","descriptor_name":"Protein Domains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000092468","descriptor_name":"Bromodomain Containing Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010802","descriptor_name":"Phylogeny","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.0c00566","doi":"https://doi.org/10.1021/acs.jmedchem.0c00566","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00566","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:32787145","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32787145","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:strathprints.strath.ac.uk:73542","doi":null,"is_oa":false,"landing_page_url":"https://strathprints.strath.ac.uk/73542/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402226","display_name":"Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I181647926","host_organization_name":"University of Strathclyde","host_organization_lineage":["https://openalex.org/I181647926"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W155704122","https://openalex.org/W594415895","https://openalex.org/W1963819309","https://openalex.org/W1966585118","https://openalex.org/W1968827652","https://openalex.org/W1970656110","https://openalex.org/W1975300700","https://openalex.org/W1976033223","https://openalex.org/W1988335148","https://openalex.org/W1990174038","https://openalex.org/W1994563738","https://openalex.org/W2014582878","https://openalex.org/W2022932992","https://openalex.org/W2024469844","https://openalex.org/W2029996142","https://openalex.org/W2036158314","https://openalex.org/W2047790609","https://openalex.org/W2052535168","https://openalex.org/W2091368230","https://openalex.org/W2093088422","https://openalex.org/W2096783705","https://openalex.org/W2102890558","https://openalex.org/W2123647733","https://openalex.org/W2129129812","https://openalex.org/W2150469988","https://openalex.org/W2155958514","https://openalex.org/W2171262570","https://openalex.org/W2270241120","https://openalex.org/W2587935821","https://openalex.org/W2625872407","https://openalex.org/W2795518453","https://openalex.org/W2797801723","https://openalex.org/W2801227197","https://openalex.org/W2889492422","https://openalex.org/W2892851404","https://openalex.org/W2897508288","https://openalex.org/W2949965749","https://openalex.org/W2964664658","https://openalex.org/W2987399803","https://openalex.org/W3000211595","https://openalex.org/W3001038414","https://openalex.org/W3011089475","https://openalex.org/W3018950211","https://openalex.org/W3039459629","https://openalex.org/W3044199686","https://openalex.org/W3045004415","https://openalex.org/W3045152887"],"related_works":["https://openalex.org/W7166663297","https://openalex.org/W4391378213","https://openalex.org/W3200958602","https://openalex.org/W4220998638","https://openalex.org/W4388687600","https://openalex.org/W4205918023","https://openalex.org/W3045152887","https://openalex.org/W3195463592","https://openalex.org/W4414770636","https://openalex.org/W2093088422"],"abstract_inverted_index":{"The":[0],"bromodomain":[1],"and":[2,117,150],"extraterminal":[3],"domain":[4],"(BET)":[5],"family":[6,36,73],"of":[7,26,34,45,52,57,62,83,103,142],"epigenetic":[8],"regulators":[9],"comprises":[10],"four":[11],"proteins":[12,28],"(BRD2,":[13],"BRD3,":[14],"BRD4,":[15],"BRDT),":[16],"each":[17],"containing":[18],"tandem":[19],"bromodomains.":[20],"To":[21,48],"date,":[22],"small":[23],"molecule":[24,87],"inhibitors":[25,63],"these":[27],"typically":[29],"bind":[30],"all":[31],"eight":[32],"bromodomains":[33,70,96,101],"the":[35,53,60,72,81,94,99,104,130],"with":[37,125],"similar":[38],"affinity,":[39],"resulting":[40],"in":[41],"a":[42,84,110],"diverse":[43],"range":[44],"biological":[46],"effects.":[47,152],"enable":[49],"further":[50],"understanding":[51],"broad":[54],"phenotype":[55],"characteristic":[56],"pan-BET":[58],"inhibition,":[59],"development":[61],"selective":[64,123,140],"for":[65,93,122],"individual,":[66],"or":[67],"sets":[68],"of,":[69],"within":[71],"is":[74,145],"required.":[75],"In":[76],"this":[77],"regard,":[78],"we":[79],"report":[80],"discovery":[82],"potent":[85],"probe":[86],"possessing":[88],"up":[89],"to":[90,129,147],"150-fold":[91],"selectivity":[92],"N-terminal":[95],"(BD1s)":[97],"over":[98],"C-terminal":[100],"(BD2s)":[102],"BETs.":[105],"Guided":[106],"by":[107],"structural":[108],"information,":[109],"specific":[111],"amino":[112],"acid":[113],"difference":[114],"between":[115],"BD1":[116,143],"BD2":[118],"domains":[119,144],"was":[120],"targeted":[121],"interaction":[124],"chemical":[126],"functionality":[127],"appended":[128],"previously":[131],"developed":[132],"I-BET151":[133],"scaffold.":[134],"Data":[135],"presented":[136],"herein":[137],"demonstrate":[138],"that":[139],"inhibition":[141],"sufficient":[146],"drive":[148],"anti-inflammatory":[149],"antiproliferative":[151]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3047589966","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2020-08-10T00:00:00"}
